PharmaEssentia Corporation
6446
Rank in Stocks
#1431
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Share Price
$37.20
Market Cap
$15.39B
Change (1 day)
-0.43%
Change (1 year)
146.23%
Country
TW
Trade PharmaEssentia Corporation (6446)
Category
Healthcare
Stock split history for PharmaEssentia Corporation (6446)
PharmaEssentia Corporation stock (symbol: 6446) underwent a total of 2 stock splits.
The most recent stock split occurred on Jul 09, 2026.
One 6446 share bought prior to Sep 11, 2025 would equal to 1.229881 6446 shares today.
The most recent stock split occurred on Jul 09, 2026.
One 6446 share bought prior to Sep 11, 2025 would equal to 1.229881 6446 shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| 2026-07-09 | 1109:1000 | x1.109 | x1.229881 |
| 2025-09-11 | 1109:1000 | x1.109 | x1.109 |
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
